Velocity Investigators Active at the American Diabetes Association (ADA) 83rd Scientific Sessions
Velocity Clinical Research
JUNE 27, 2023
Rosenstock is the lead investigator for Novo Nordisk’s ONWARDS 1 program exploring the first investigational once-weekly insulin. “In In ONWARDS 1, insulin icodec allowed people to spend significantly more Time in Range, with comparable Time below Range vs. once-daily basal insulin glargine U100,” said Dr. Rosenstock. “A
Let's personalize your content